Priyal Amin
Nurse Practitioner · Beaumont, CANPI 1366177479
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.4% of the total across 78 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 9.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,384, more than ten times the $20 reported in 2023.
Across 78 payments — averaging $26.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$195
- Novartis$185
- Johnson & Johnson$145
- Bristol Myers Squibb$136
- Takeda Pharmaceuticals U.S.A., Inc.$107
- Regeneron Healthcare Solutions, Inc.$106
- plus $1K from 26 others
What the payments were for
- Food & beverage$1,85991%
- Education$1759%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 3 | $195 |
| Novartis | 8 | $185 |
| Johnson & Johnson | 5 | $145 |
| Bristol Myers Squibb | 5 | $136 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $107 |
| Regeneron Healthcare Solutions, Inc. | 4 | $106 |
| Puma Biotechnology, Inc. | 4 | $102 |
| AbbVie | 4 | $97 |
| Merck | 4 | $91 |
| Lilly USA, LLC | 4 | $86 |
| Agios Pharmaceuticals, Inc. | 3 | $76 |
| Sobi, Inc | 3 | $67 |
| EMD Serono, Inc. | 2 | $62 |
| Boehringer Ingelheim | 2 | $59 |
| E.r. Squibb & Sons, L.L.C. | 3 | $57 |
| Bayer | 2 | $55 |
| Genentech USA, Inc. | 2 | $44 |
| Pfizer | 2 | $39 |
| Taiho Oncology, Inc. | 1 | $30 |
| Karyopharm Therapeutics Inc. | 1 | $29 |
| Legend Biotech USA Inc. | 1 | $28 |
| Incyte Corporation | 1 | $28 |
| AstraZeneca | 1 | $25 |
| Array Biopharma Inc | 1 | $23 |
| Novocure Inc. | 1 | $23 |
| Pharmaessentia USA Corporation | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $20 |
| AVEO Pharmaceuticals, Inc. | 1 | $20 |
| Melinta Therapeutics, LLC | 1 | $20 |
| Geron Corporation | 1 | $19 |
| GSK | 1 | $17 |
| Eisai Inc. | 1 | $17 |
How this compares
$2,034 in reported general payments places this provider in the 85th percentile of 6,779 nurse practitioner providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $182 |
| Potassium Chloride | 17 | $155 |
| Levothyroxine Sodium | 13 | $96 |
| Atorvastatin Calcium | 12 | $42 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Beaumont
- Rhonda HewittStanford$917K
- Linda TrinhIrvine$884K
- Denise SinagaNorthridge$728K
- Debbie TaySanta Monica$642K
- Joe GorelickCampbell$638K
- Lynsey LakinArcadia$540K
- Kelly ChoiRancho Cucamonga$483K
- Hamta ZareStanford$428K
- Shawna ChrismanRoseville$425K
- Angelina CollinsSan Diego$356K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.